User:Tinarss/Estrone/progesterone

We plan to separate the combination medication and address the following: side effects, adverse effects, contraindications, indications, availability, and pricing.

role in pediatrics

This combination medication is currently not available in the United States, where progesterone alone or in combination with estrogen is used to improve menopausal symptoms.

 Amenorrhea 

is the absence of one or more menstrual periods.

 Estrone: 

Side Effects:

Adverse Effects:

Contraindications:

Indications:

Availability:

Pricing

 Progesterone: 

Progesterone can also be used to prevent giving birth too soon. In women who are pregnant with a single fetus, asymptomatic in the prenatal stage, and at a high risk of giving pre-term birth spontaneously (going into labor spontaneously before 34 weeks), vaginal progesterone has been found to be effective in preventing spontaneous pre-term birth. Women who are at a high risk of giving pre-term birth spontaneously are those who have a short cervix of less than 25 mm or have previously given pre-term birth spontaneously. Although pre-term births are generally considered to be less than 37 weeks, vaginal progesterone is associated with fewer pre-term births of less than 34 weeks.

Autoimmune progesterone dermatitis (APD) is a rare skin condition that develops as a reaction to too much progesterone in the body during the menstrual cycle.

Current data shows that micronized progesterone, which is chemically identical to the progesterone produced in women's bodies, in combination with estrogen in menopausal hormone therapy does not seem to have significant effects on venous thromboembolism (blood clots in the veins), and ischemic stroke (lack of blood flow to the brain due to blockage of a blood vessel that supplies the brain). However, more studies need to be conducted to see whether or not micronized progesterone alone or in combined menopausal hormone therapy changes the risk of heart attacks.

Despite suggestions for using hormone therapy to prevent loss of muscle mass in post-menopausal women (women who are 50 years or older), menopausal hormone therapy involving either estrogen alone or estrogen and progesterone has not been found to preserve muscle mass. Menopausal hormone therapy also does not result in body weight reduction, BMI reduction, or change in glucose metabolism.

Micronized progesterone cream and micronized progesterone in combined menopausal hormone therapy are both beneficial in preventing skin aging in post-menopausal women. However, there have not been any studies done yet on the effects of micronized progesterone on hair loss due to menopause.

Transdermal progesterone (skin patch) and oral micronized progesterone have each been shown to be effective treatments for certain symptoms of menopause such as hot flashes and night sweats, otherwise known as vasomotor symptoms or VMS.

Side Effects:

Adverse Effects:

Contraindications:

Indications:

Availability:

Pricing: